XTX Markets’s Edwards Lifesciences EW Stock Holding History

XTX Markets’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-4,503	Closed	-$283K	–	166
2020 Q1	$283K	Buy	+4,503	New	+$325K	0.93%	52

Other funds holding EW

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return

XTX Markets's EW Position: Q2 2020 in Review

XTX Markets sold out of Edwards Lifesciences (EW) in Q2 2020, closing a stake of 4,503 shares — an estimated $283K sold.

XTX Markets first reported a position in EW in Q1 2020 and held it in 1 quarter. The position peaked at $283K in Q1 2020. 1,047 funds tracked by Wall St. Rank hold EW as of Q2 2020.

XTX Markets reported no remaining Edwards Lifesciences position as of Q2 2020 after selling out during the quarter.
XTX Markets sold 4,503 Edwards Lifesciences shares in Q2 2020, an estimated $283K.
XTX Markets first reported a position in Edwards Lifesciences in Q1 2020 and held it in 1 quarter.
XTX Markets's Edwards Lifesciences position peaked at $283K in Q1 2020.
1,047 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2020.

Based on XTX Markets's 13F filing for Q2 2020, filed 23 Jul 2020.